Frank Gebhardt

1.4k total citations
20 papers, 1.1k citations indexed

About

Frank Gebhardt is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Frank Gebhardt has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Frank Gebhardt's work include HER2/EGFR in Cancer Research (5 papers), Molecular Biology Techniques and Applications (3 papers) and RNA modifications and cancer (3 papers). Frank Gebhardt is often cited by papers focused on HER2/EGFR in Cancer Research (5 papers), Molecular Biology Techniques and Applications (3 papers) and RNA modifications and cancer (3 papers). Frank Gebhardt collaborates with scholars based in Germany, United Kingdom and United States. Frank Gebhardt's co-authors include Burkhard Brandt, Kurt S. Zänker, Beate Schultheis, Horst Bürger, Dirk Strumberg, Elisabetta Dejana, Graeme M. Birdsey, Valérie Amsellem, Justin C. Mason and Anna M. Randi and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Frank Gebhardt

19 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frank Gebhardt Germany 11 658 399 319 203 111 20 1.1k
Ivan Ischenko Germany 19 621 0.9× 507 1.3× 140 0.4× 269 1.3× 105 0.9× 22 1.2k
Vinay Sagar United States 19 712 1.1× 361 0.9× 214 0.7× 231 1.1× 83 0.7× 46 1.3k
Eva Cubillo Spain 9 794 1.2× 528 1.3× 115 0.4× 259 1.3× 102 0.9× 10 1.1k
Philippe Pujuguet Belgium 16 542 0.8× 446 1.1× 140 0.4× 153 0.8× 71 0.6× 22 1.1k
Maher N. Younes United States 19 517 0.8× 498 1.2× 158 0.5× 169 0.8× 83 0.7× 21 1.1k
Dorian Korz United States 10 710 1.1× 295 0.7× 137 0.4× 267 1.3× 119 1.1× 11 1.2k
Fumihiko Matsuno Japan 15 590 0.9× 345 0.9× 108 0.3× 226 1.1× 53 0.5× 31 986
Lingtao Wu United States 19 716 1.1× 333 0.8× 150 0.5× 91 0.4× 202 1.8× 34 1000
Dina Leitão Portugal 14 434 0.7× 673 1.7× 193 0.6× 296 1.5× 73 0.7× 28 1.0k
Sonja M. Markwart United States 15 459 0.7× 240 0.6× 148 0.5× 178 0.9× 30 0.3× 15 847

Countries citing papers authored by Frank Gebhardt

Since Specialization
Citations

This map shows the geographic impact of Frank Gebhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Gebhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Gebhardt more than expected).

Fields of papers citing papers by Frank Gebhardt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Gebhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Gebhardt. The network helps show where Frank Gebhardt may publish in the future.

Co-authorship network of co-authors of Frank Gebhardt

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Gebhardt. A scholar is included among the top collaborators of Frank Gebhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Gebhardt. Frank Gebhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Schultheis, Beate, Dirk Strumberg, Jan Kuhlmann, et al.. (2016). A phase Ib/IIa study of combination therapy with gemcitabine and Atu027 in patients with locally advanced or metastatic pancreatic adenocarcinoma.. Journal of Clinical Oncology. 34(4_suppl). 385–385. 38 indexed citations
3.
Schultheis, Beate, Dirk Strumberg, Ansgar Santel, et al.. (2014). First-in-Human Phase I Study of the Liposomal RNA Interference Therapeutic Atu027 in Patients With Advanced Solid Tumors. Journal of Clinical Oncology. 32(36). 4141–4148. 206 indexed citations
4.
Strumberg, Dirk, Beate Schultheis, Ansgar Santel, et al.. (2013). Antimetastatic Activity of Atu027, a Liposomal Sirna Formulation, Targeting Protein Kinase N3: Final Results of a Phase I Study. Annals of Oncology. 24. i7–i7. 3 indexed citations
5.
Schultheis, Beate, Dirk Strumberg, Ansgar Santel, et al.. (2013). First-in-human phase I study of the liposomal RNAi therapeutic Atu027 in patients with advanced cancer.. Journal of Clinical Oncology. 31(15_suppl). 2508–2508. 1 indexed citations
6.
Eberlein, Cath, James Legg, Frank Gebhardt, et al.. (2013). Abstract 1616: Survivin regulates endothelial cell proliferation, survival and angiogenesis.. Cancer Research. 73(8_Supplement). 1616–1616. 1 indexed citations
7.
Strumberg, Dirk, Beate Schultheis, W. Meyer‐Sabellek, et al.. (2012). Antimetastatic activity of Atu027, a liposomal small interfering RNA formulation, targeting protein kinase N3 (PKN3): Final results of a phase I study in patients with advanced solid tumors.. Journal of Clinical Oncology. 30(15_suppl). e13597–e13597. 4 indexed citations
8.
Birdsey, Graeme M., Nicola H. Dryden, Valérie Amsellem, et al.. (2008). Transcription factor Erg regulates angiogenesis and endothelial apoptosis through VE-cadherin. Blood. 111(7). 3498–3506. 207 indexed citations
9.
Birdsey, Graeme M., Valérie Amsellem, Frank Gebhardt, et al.. (2008). THE TRANSCRIPTION FACTOR ERG REGULATES ANGIOGENESIS AND ENDOTHELIAL APOPTOSIS THROUGH VE-CADHERIN. Atherosclerosis. 199(2). 465–465. 12 indexed citations
10.
Brandt, Burkhard, et al.. (2003). Double- and Competitive-Differential PCR for Gene Dosage Quantitation. Humana Press eBooks. 39. 347–356. 1 indexed citations
11.
Gebhardt, Frank, Frauke Leenders, Frank Czauderna, et al.. (2002). GeneBlocs Are Powerful Tools to Study and Delineate Signal Transduction Processes That Regulate Cell Growth and Transformation. Antisense and Nucleic Acid Drug Development. 12(3). 131–143. 27 indexed citations
12.
Buerger, Horst, Frank Gebhardt, Hartmut Schmidt, et al.. (2000). Length and loss of heterozygosity of an intron 1 polymorphic sequence of egfr is related to cytogenetic alterations and epithelial growth factor receptor expression.. PubMed. 60(4). 854–7. 130 indexed citations
13.
Gebhardt, Frank, Horst Bürger, & Burkhard Brandt. (2000). Modulation of EGFR gene transcription by secondary structures, a polymorphic repetitive sequence and mutations--a link between genetics and epigenetics.. PubMed. 15(3). 929–36. 48 indexed citations
14.
Gebhardt, Frank, Horst Bürger, & Burkhard Brandt. (2000). Modulation of EGFR Gene Transcription by a Polymorphic Repetitive Sequence – a Link between Genetics and Epigenetics. The International Journal of Biological Markers. 15(1). 105–110. 32 indexed citations
15.
Gebhardt, Frank, Kurt S. Zänker, & Burkhard Brandt. (1999). Modulation of Epidermal Growth Factor Receptor Gene Transcription by a Polymorphic Dinucleotide Repeat in Intron 1. Journal of Biological Chemistry. 274(19). 13176–13180. 314 indexed citations
16.
Beckmann, Alf, Frank Gebhardt, & Burkhard Brandt. (1998). Direct quantification of polymerase chain reaction fragments using field-amplified sample injection in capillary zone electrophoresis for gene dosage estimation. Journal of Chromatography B. 710. 75–8012. 4 indexed citations
17.
Gebhardt, Frank, Kurt S. Zänker, & Burkhard Brandt. (1998). Differential Expression of Alternatively Spliced c-erbB-2 mRNA in Primary Tumors, Lymph Node Metastases, and Bone Marrow Micrometastases from Breast Cancer Patients. Biochemical and Biophysical Research Communications. 247(2). 319–323. 20 indexed citations
18.
Beckmann, Alf, Frank Gebhardt, & Burkhard Brandt. (1998). Direct quantification of polymerase chain reaction fragments using field-amplified sample injection in capillary zone electrophoresis for gene dosage estimation. Journal of Chromatography B Biomedical Sciences and Applications. 710(1-2). 75–80. 6 indexed citations
19.
Brandt, Burkhard, Alf Beckmann, Frank Gebhardt, et al.. (1997). Translational research studies of erbB oncogenes: selection strategies for breast cancer treatment. Cancer Letters. 118(2). 143–151. 6 indexed citations
20.
Wahlig, H, et al.. (1969). [Pharmacokinetics of gentamicin in serum and urine].. PubMed. 64(34). 1497–502. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ivan Ischenko Breakdown of academic impact, for papers by Vinay Sagar Breakdown of academic impact, for papers by Eva Cubillo Breakdown of academic impact, for papers by Philippe Pujuguet Breakdown of academic impact, for papers by Maher N. Younes Breakdown of academic impact, for papers by Dorian Korz Breakdown of academic impact, for papers by Fumihiko Matsuno Breakdown of academic impact, for papers by Lingtao Wu Breakdown of academic impact, for papers by Dina Leitão Breakdown of academic impact, for papers by Sonja M. Markwart
Rankless by CCL
2026